Navigation Links
Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinson's Disease
Date:7/17/2008

NEW YORK, July 17 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative. This annual MJFF program provides intellectual and financial resources to help push potential PD drug targets forward toward clinical trials and ultimately the nearly five million Parkinson's patients worldwide.

"The discovery of a new potential therapeutic target generates great excitement among patients and researchers," said Katie Hood, CEO of The Michael J. Fox Foundation. "But to attract an industry sponsor with the resources and expertise to chaperone it through optimization, preclinical work and ultimately clinical testing, that target needs a critical mass of evidence behind it, demonstrating that it is involved in the disease and that manipulating it impacts symptoms or progression. MJFF's Target Validation program helps accumulate this evidence, reducing the risk of investment for industry and building the case for prioritization of the most promising targets in the pipeline."

Target validation is an essential and historically under-resourced phase of drug development in which researchers work to determine whether a molecule or mechanism of interest is a true drug target. While researchers have continued to identify novel targets in recent years through genetic, biochemical and epidemiological studies, a lack of funding for validation studies has long been a major roadblock to the efficient translation of these discoveries into practical therapies that benefit people living with PD.

Projects funded in this cohort of Target Validation awardees fall into three categories: targets for therapies to alleviate symptoms of PD; approaches focused on dyskinesias, the excessive, uncontrollable movements brought on by long-term dopamine replacement therapy; and targets with potential to slow or stop progression of Parkin
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
2. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
3. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
4. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
5. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
6. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
7. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
8. Childrens Brain Tumor Foundations Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
9. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
10. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
11. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Attorney Advertising -- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  The investigation focuses on whether the ... On May 22, 2013, Shares of ... after the company announced in regulatory filing that ...
(Date:5/22/2013)... , May 22, 2013   Accuray Incorporated ... its management is scheduled to present at the 2013 ... on Thursday, June 6, 2013 at 1:30 ... of the presentation will be available online from the ... . The webcast replay of the presentation ...
(Date:5/22/2013)... , May 22, 2013 JenaValve Technology, Inc., a ... implantation (TAVI) systems for the treatment of aortic valve disease, ... enaValve Eval U ation of Long Term P erformance ... E vere Ao R tic Stenosis (JUPITER) Registry at EuroPCR ... registry to evaluate five-year long term safety and effectiveness of ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4
... Oct. 6 Medco Health Solutions, Inc. (NYSE: MHS ... 2010 earnings guidance in a press release before the market ... release, management will hold a conference call to review the ... , To access the live conference call via telephone: ...
... Oct. 6 Foundation Radiology Group (FRG), the ... in downtown Pittsburgh, recently added Shawn Kramer, Director ... , Kramer, a 20-year client services veteran, has ... Services, Ceridian, and XO Communications. , As the ...
Cached Medicine Technology:Medco Announces Date for Third-Quarter 2009 Financial Results; Company to Provide 2010 Earnings Guidance 2Foundation Radiology Group Adds Shawn Kramer, Director of Client Services 2
(Date:5/23/2013)... May 23, 2013 Shirataki noodles ... used as part of a diet strategy. These noodles ... of the konjac plant. When losing weight, diet and ... an informational website helping dieters not only research shirataki ... suggestions on where to buy them. Shirataki noodles ...
(Date:5/23/2013)... Fresno, California (PRWEB) May 23, 2013 ... is sponsoring an exciting celebrity workout in conjunction with ... June 8th, at 8AM. Here, training participants will get ... Kim Lyons (from The Biggest Loser, The Dr. Oz ... Schlierkamp (winner of Mr. Universe) and the undefeated UFC ...
(Date:5/23/2013)... May 23, 2013 911 Signal USA is ... will begin on May 22 and run through May 24, ... information about the company's emergency vehicle lights and ... 2013 Dodge Charger at the expo. , The Charger has ... the market and can be seen by visiting 911 Signal ...
(Date:5/23/2013)... 2013 Daimer Industries, Inc.®, the ... detailing systems , including outstanding car wash equipment ... well as other popular cleaning machines with many ... is now offering the Super Max™ 7000, an ... a myriad of cleaning applications, such as maintaining ...
(Date:5/22/2013)... MileageAds.com, an American based full service ad network, has ... and Bonds Sector to display advertisements through their reputable ... have the opportunity to take advantage of professional branding ... who accept Mileageads.com’s invitation will be able to position ... audience on the internet who are in need ...
Breaking Medicine News(10 mins):Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2Health News:Kim Lyons, Gunter Schlierkamp, & Daniel Cormier To Host Fresno Charity Workout 2Health News:Kim Lyons, Gunter Schlierkamp, & Daniel Cormier To Host Fresno Charity Workout 3Health News:911 Signal USA Attends the 2013 Southwest Police Fleet Expo 2Health News:Commercial Pressure Washer Debuted By Daimer Industries For Wheelchair Cleaning 2Health News:Commercial Pressure Washer Debuted By Daimer Industries For Wheelchair Cleaning 3Health News:Commercial Pressure Washer Debuted By Daimer Industries For Wheelchair Cleaning 4Health News:Mileageads.com Ad Network Now Invites Companies in Stocks and Bonds Services Sector to Advertise on Their Ad Network 2
... ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA ), today announced ... 6, 2008, after the U.S. markets close. ISTA will,host ... these,results and provide a commercial and pipeline update at ... the live conference call, U.S. and Canadian participants may,dial ...
... are less effective, researchers find , , TUESDAY, March 4 ... expensive, they tend to report more benefit than when they ... , In fact, 85 percent of people given what they ... pain, compared with 61 percent of those given the same ...
... Calif., March 4 STAAR Surgical,Company (Nasdaq: ... of,minimally invasive ophthalmic products, congratulates Dr. Brian Boxer,Wachler ... Show this morning,correcting NBCSports.com columnist Alan Abrahamson,s vision ... is the only foldable, minimally invasive lens approved,in ...
... Independence Blue Cross and its,affiliates and The ... reached a new seven-year agreement. A term of ... first in the history of this key partnership.,The ... between Independence and Children,s Hospital, serving the,special health ...
... Advocates Converge on Washington, D.C. from Across the Country ... The Autism Society of,America will host its 2008 ... to,increase awareness and understanding of autism issues among federal,policymakers. ... the autism spectrum, and families affected by autism must ...
... growth factor, leads to shorter stature but longer life , , ... that restricts a particular growth factor may be one of ... study suggests. , This mutation, which seems to decrease the ... but longer life. Exactly why this might lengthen someone,s life ...
Cached Medicine News:Health News:Price Plays Part in Perceived Power of Medication 2Health News:Price Plays Part in Perceived Power of Medication 3Health News:STAAR Surgical's Visian ICL Procedure Performed Live on NBC's Today show 2Health News:STAAR Surgical's Visian ICL Procedure Performed Live on NBC's Today show 3Health News:Independence Blue Cross and The Children's Hospital of Philadelphia Reach Seven-Year Agreement 2Health News:Independence Blue Cross and The Children's Hospital of Philadelphia Reach Seven-Year Agreement 3Health News:Autism Society of America Hosts Day on the Hill 2Health News:Rare Gene Mutation Plays Role in Longevity 2Health News:Rare Gene Mutation Plays Role in Longevity 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: